Xinhua News Agency, Shanghai, September 1st. Shanghai Fosun Pharmaceutical Group supplied the first batch of 932,000 doses of mRNA new crown vaccine Fubitai in Taiwan. It will depart from Luxembourg Airport on the afternoon of September 1st, Beijing time, and is expected to arrive in the morning of September 2nd. Taipei.

It is reported that the second batch of about 910,000 doses of Fubitai vaccine will be shipped in a week.

  Fosun Pharma and the German BioNTech company jointly developed the mRNA Forbitux vaccine in Hong Kong and Macau in the first half of this year, which received emergency use approval and special license import approval, and was put into the government vaccination program in Hong Kong and Macau Special Administrative Region.

  In July this year, Fosun Pharma signed a vaccine sales and supply agreement for a total of 15 million doses with relevant enterprises and private organizations in Taiwan.

According to Taiwanese media reports, the island will open to register for vaccination with Fubitai on August 28, and the first batch of Fubitai vaccine will be given priority to school students aged 12 to 17 years old.